Schrodinger, Inc. Net Profit Margin 2019-2024 | SDGR
Schrodinger, Inc. net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Schrodinger, Inc. Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $0.19B | $-0.18B | -92.23% |
| 2024-06-30 | $0.20B | $-0.20B | -100.50% |
| 2024-03-31 | $0.19B | $-0.14B | -76.19% |
| 2023-12-31 | $0.22B | $0.04B | 18.43% |
| 2023-09-30 | $0.20B | $0.04B | 22.00% |
| 2023-06-30 | $0.19B | $0.07B | 34.02% |
| 2023-03-31 | $0.20B | $0.01B | 7.11% |
| 2022-12-31 | $0.18B | $-0.15B | -82.32% |
| 2022-09-30 | $0.17B | $-0.15B | -90.00% |
| 2022-06-30 | $0.16B | $-0.15B | -90.80% |
| 2022-03-31 | $0.16B | $-0.14B | -87.10% |
| 2021-12-31 | $0.14B | $-0.10B | -73.19% |
| 2021-09-30 | $0.13B | $-0.08B | -64.80% |
| 2021-06-30 | $0.12B | $-0.04B | -34.71% |
| 2021-03-31 | $0.11B | $-0.01B | -8.77% |
| 2020-12-31 | $0.11B | $-0.02B | -22.22% |
| 2020-09-30 | $0.10B | $-0.02B | -19.80% |
| 2020-06-30 | $0.10B | $-0.04B | -37.89% |
| 2020-03-31 | $0.09B | $-0.03B | -37.36% |
| 2019-12-31 | $0.09B | $-0.03B | -30.23% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||